Her research led to her specialising in tension
myoneural syndrome and her work with individuals and groups with the aim of preventing and eradicating long-term.
The first line of treatment is anti-cholinesterase therapy, which involves administering medications that block the breakdown of acetylcholine in the synapse in the
myoneural junctions.
Myasthenia gravis is a disorder of the
myoneural junction (where the motor neurons from the brain and spinal cord connect and innervate the skeletal muscles).
Exposure to organophosphate compounds will, therefore, interfere with synaptic transmission peripherally at muscarinic neuroeffector junctions and nicotinic receptors within sympathetic ganglia and at skeletal
myoneural junctions.
Myasthenia Gravis affects the
myoneural junction so, although orbital in origin, it has the characteristics of a neurogenic palsy.
She discovered Dr Sarno's work on TMS (Tension
Myoneural Syndrome), and visited him in New York and now she dedicates her practice to working with people who have TMS and their recovery.